30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Vor Biopharma Inc (VOR)

Track

Over the last 90 days, Vor Biopharma Inc. has seen significant insider selling, totaling over $49 million. RA CAPITAL MANAGEMENT, L.P. was the primary seller, executing multiple transactions. There were no insider purchases reported during this period. The company's stock has experienced a modest 4.4% increase over the same timeframe.
Stock chart
Ticker: VOR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RA CAPITAL MANAGEMENT, L.P.
1 sale — total 2,604,416 USD
Sale 22 Apr 2026
Value US$1,041,975.75 | Price 286.81 | Shares 51,461
Sale 20 Apr 2026
Value US$1,393,542.50 | Price 257.31 | Shares 12,607
Sale 17 Apr 2026
Value US$7,462,931.08 | Price 16.28 | Shares 458,411
Sale 15 Apr 2026
Value US$858,840.44 | Price 16.01 | Shares 53,644
Sale 14 Apr 2026
Value US$2,455,147.95 | Price 15.97 | Shares 153,735
Sale 13 Apr 2026
Value US$8,569,351.50 | Price 16.15 | Shares 530,610
Sale 10 Apr 2026
Value US$13,041.00 | Price 15.75 | Shares 828
Sale 9 Apr 2026
Value US$2,242,984.59 | Price 16.59 | Shares 135,201
Sale 8 Apr 2026
Value US$2,212,876.42 | Price 16.91 | Shares 130,862
Sale 8 Apr 2026
Value US$5,764,909.44 | Price 16.32 | Shares 353,242
Sale 6 Apr 2026
Value US$125,337.50 | Price 18.50 | Shares 6,775
Sale 6 Apr 2026
Value US$774,241.68 | Price 17.31 | Shares 44,728
Sale 6 Apr 2026
Value US$8,878,318.54 | Price 16.51 | Shares 537,754
Sale 2 Apr 2026
Value US$29,066.50 | Price 19.06 | Shares 1,525
Sale 2 Apr 2026
Value US$4,711,999.25 | Price 18.23 | Shares 258,475
Sale 30 Oct 2025
Value US$617,424.48 | Price 25.12 | Shares 24,579
Sale 29 Oct 2025
Value US$6,343,283.96 | Price 25.22 | Shares 251,518
Sale 28 Oct 2025
Value US$1,028,090.94 | Price 28.18 | Shares 36,483
Sale 28 Oct 2025
Value US$2,380,138.80 | Price 27.10 | Shares 87,828
Sale 27 Oct 2025
Value US$2,557,260.92 | Price 28.12 | Shares 90,941
Sale 24 Oct 2025
Value US$1,494,193.45 | Price 28.01 | Shares 53,345
Sale 23 Oct 2025
Value US$2,153,408.80 | Price 28.01 | Shares 76,880
Sale 21 Oct 2025
Value US$703,508.97 | Price 28.11 | Shares 25,027
Sale 21 Oct 2025
Value US$6,015.00 | Price 30.08 | Shares 200
Sale 20 Oct 2025
Value US$38,764.44 | Price 30.12 | Shares 1,287
Sale 20 Oct 2025
Value US$197,376.36 | Price 30.12 | Shares 6,553
Sale 20 Oct 2025
Value US$409,397.71 | Price 29.63 | Shares 13,817
Sale 20 Oct 2025
Value US$2,084,944.58 | Price 29.63 | Shares 70,366
Sale 20 Oct 2025
Value US$349,101.46 | Price 30.05 | Shares 11,616
Proposed sale 20 Oct 2025
Value US$444,510.72 | Price 29.43 | Shares 15,104
Proposed sale 20 Oct 2025
Value US$2,263,726.17 | Price 29.43 | Shares 76,919
Sale 17 Oct 2025
Value US$31,868.00 | Price 31.00 | Shares 1,028
Sale 17 Oct 2025
Value US$746,118.86 | Price 30.22 | Shares 24,689
Proposed sale 17 Oct 2025
Value US$1,241,664.00 | Price 29.00 | Shares 42,816
Proposed sale 17 Oct 2025
Value US$6,323,247.00 | Price 29.00 | Shares 218,043
Sale 17 Oct 2025
Value US$77,252.00 | Price 31.00 | Shares 2,492
Sale 17 Oct 2025
Value US$393,421.00 | Price 31.00 | Shares 12,691
Sale 17 Oct 2025
Value US$182,891.20 | Price 30.28 | Shares 6,040
Sale 17 Oct 2025
Value US$931,352.24 | Price 30.28 | Shares 30,758
Sale 17 Oct 2025
Value US$998,350.08 | Price 29.12 | Shares 34,284
Sale 17 Oct 2025
Value US$5,084,177.28 | Price 29.12 | Shares 174,594
Sale 16 Oct 2025
Value US$61,549.15 | Price 30.45 | Shares 2,021
Sale 16 Oct 2025
Value US$125.40 | Price 31.35 | Shares 4
Sale 16 Oct 2025
Value US$627.00 | Price 31.35 | Shares 20
Sale 16 Oct 2025
Value US$94,358.88 | Price 30.36 | Shares 3,108
Sale 16 Oct 2025
Value US$480,477.36 | Price 30.36 | Shares 15,826
Sale 16 Oct 2025
Value US$639,293.28 | Price 29.32 | Shares 21,804
Sale 16 Oct 2025
Value US$3,255,722.12 | Price 29.32 | Shares 111,041
Proposed sale 16 Oct 2025
Value US$724,058.96 | Price 29.06 | Shares 24,916
Proposed sale 16 Oct 2025
Value US$3,687,336.22 | Price 29.06 | Shares 126,887
Sale 15 Oct 2025
Value US$258,712.43 | Price 32.77 | Shares 7,894
Sale 15 Oct 2025
Value US$1,567,364.97 | Price 32.05 | Shares 48,910
Sale 15 Oct 2025
Value US$461,117.61 | Price 31.05 | Shares 14,851
Sale 15 Oct 2025
Value US$1,433.82 | Price 31.17 | Shares 46
Sale 15 Oct 2025
Value US$7,293.78 | Price 31.17 | Shares 234
Sale 15 Oct 2025
Value US$256,131.20 | Price 30.55 | Shares 8,384
Sale 15 Oct 2025
Value US$1,304,454.45 | Price 30.55 | Shares 42,699
Proposed sale 15 Oct 2025
Value US$254,754.60 | Price 30.22 | Shares 8,430
Proposed sale 15 Oct 2025
Value US$1,297,435.26 | Price 30.22 | Shares 42,933
Sale 14 Oct 2025
Value US$1,020,786.83 | Price 30.32 | Shares 33,668
Sale 13 Oct 2025
Value US$77,225.76 | Price 33.09 | Shares 2,334
Sale 13 Oct 2025
Value US$636,560.35 | Price 32.36 | Shares 19,672
Sale 10 Oct 2025
Value US$1,269,132.86 | Price 30.97 | Shares 40,983
Sale 9 Oct 2025
Value US$487,439.02 | Price 32.41 | Shares 15,042
Sale 9 Oct 2025
Value US$1,080,172.34 | Price 31.92 | Shares 33,842
Sale 8 Oct 2025
Value US$492,285.34 | Price 34.34 | Shares 14,336
Sale 8 Oct 2025
Value US$2,056,471.83 | Price 33.75 | Shares 60,926
Sale 7 Oct 2025
Value US$934,710.53 | Price 33.84 | Shares 27,624
Sale 6 Oct 2025
Value US$685,830.19 | Price 37.77 | Shares 18,156
Sale 6 Oct 2025
Value US$1,293,565.94 | Price 37.12 | Shares 34,847
Sale 6 Oct 2025
Value US$639,391.97 | Price 36.00 | Shares 17,760
Sale 3 Oct 2025
Value US$179,316.82 | Price 38.14 | Shares 4,701
Sale 3 Oct 2025
Value US$119,593.92 | Price 37.37 | Shares 3,200
Sale 2 Oct 2025
Value US$224,290.70 | Price 42.32 | Shares 5,300
Sale 2 Oct 2025
Value US$521,706.73 | Price 40.13 | Shares 13,001
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-24 2026-04-22 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
51,461 +9.4%
286.81
US$1,041,976 		51,461 +9.4% 286.81 US$1,041,976
2026-04-21 2026-04-20 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
12,607 +43.4%
257.31
US$1,393,543 		12,607 +43.4% 257.31 US$1,393,543
2026-04-21 2026-04-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
24,437 +11.1%
180.26
US$832,439 		24,437 +11.1% 180.26 US$832,439
2026-04-15 2026-04-15 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
53,644 -1.6%
16.01
US$858,840 		53,644 -1.6% 16.01 US$858,840
2026-04-15 2026-04-14 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
153,735 -4.5%
15.97
US$2,455,148 		153,735 -4.5% 15.97 US$2,455,148
2026-04-15 2026-04-13 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
530,610 -13.5%
16.15
US$8,569,352 		530,610 -13.5% 16.15 US$8,569,352
2026-04-10 2026-04-10 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
828 -0.0%
15.75
US$13,041 		828 -0.0% 15.75 US$13,041
2026-04-10 2026-04-09 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
135,201 -3.3%
16.59
US$2,242,985 		135,201 -3.3% 16.59 US$2,242,985
2026-04-10 2026-04-08 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
130,862 -3.1%
16.91
US$2,212,876 		130,862 -3.1% 16.91 US$2,212,876
2026-04-10 2026-04-08 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
353,242 -7.8%
16.32
US$5,764,909 		353,242 -7.8% 16.32 US$5,764,909
2026-04-06 2026-04-06 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
6,775 -0.1%
18.50
US$125,338 		6,775 -0.1% 18.50 US$125,338
2026-04-06 2026-04-06 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
44,728 -1.0%
17.31
US$774,242 		44,728 -1.0% 17.31 US$774,242
2026-04-06 2026-04-06 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
537,754 -10.5%
16.51
US$8,878,319 		537,754 -10.5% 16.51 US$8,878,319
2026-04-06 2026-04-02 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,525 -0.0%
19.06
US$29,066 		1,525 -0.0% 19.06 US$29,066
2026-04-06 2026-04-02 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
258,475 -4.8%
18.23
US$4,711,999 		258,475 -4.8% 18.23 US$4,711,999
2025-10-30 2025-10-30 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
24,579 -3.1%
25.12
US$617,424 		24,579 -3.1% 25.12 US$617,424
2025-10-30 2025-10-29 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
251,518 -23.8%
25.22
US$6,343,284 		251,518 -23.8% 25.22 US$6,343,284
2025-10-30 2025-10-28 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
36,483 -3.3%
28.18
US$1,028,091 		36,483 -3.3% 28.18 US$1,028,091
2025-10-30 2025-10-28 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
87,828 -7.4%
27.10
US$2,380,139 		87,828 -7.4% 27.10 US$2,380,139
2025-10-27 2025-10-27 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
90,941 -7.2%
28.12
US$2,557,261 		90,941 -7.2% 28.12 US$2,557,261
2025-10-27 2025-10-24 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
53,345 -4.0%
28.01
US$1,494,193 		53,345 -4.0% 28.01 US$1,494,193
2025-10-27 2025-10-23 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
76,880 -5.5%
28.01
US$2,153,409 		76,880 -5.5% 28.01 US$2,153,409
2025-10-22 2025-10-21 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
25,027 -1.8%
28.11
US$703,509 		25,027 -1.8% 28.11 US$703,509
2025-10-21 2025-10-21 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
200 -0.0%
30.08
US$6,015 		200 -0.0% 30.08 US$6,015
2025-10-22 2025-10-20 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,287 -100.0%
30.12
US$38,764 		1,287 -100.0% 30.12 US$38,764
2025-10-22 2025-10-20 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
6,553 -0.5%
30.12
US$197,376 		6,553 -0.5% 30.12 US$197,376
2025-10-22 2025-10-20 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
13,817 -91.5%
29.63
US$409,398 		13,817 -91.5% 29.63 US$409,398
2025-10-22 2025-10-20 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
70,366 -4.7%
29.63
US$2,084,945 		70,366 -4.7% 29.63 US$2,084,945
2025-10-21 2025-10-20 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
11,616 -1.0%
30.05
US$349,101 		11,616 -1.0% 30.05 US$349,101
2025-10-20 2025-10-20 PrS Proposed sale
RA Capital Nexus Fund, L.P.

Director; 10% Stockholder

Non-Executive Director Large shareholder
15,104
29.43
US$444,511 		15,104 29.43 US$444,511
2025-10-20 2025-10-20 PrS Proposed sale
RA Capital Healthcare Fund LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
76,919
29.43
US$2,263,726 		76,919 29.43 US$2,263,726
2025-10-21 2025-10-17 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
1,028 -0.1%
31.00
US$31,868 		1,028 -0.1% 31.00 US$31,868
2025-10-21 2025-10-17 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
24,689 -2.0%
30.22
US$746,119 		24,689 -2.0% 30.22 US$746,119
2025-10-17 2025-10-17 PrS Proposed sale
RA Capital Nexus Fund, L.P.

Director; 10% Stockholder

Non-Executive Director Large shareholder
42,816
29.00
US$1,241,664 		42,816 29.00 US$1,241,664
2025-10-17 2025-10-17 PrS Proposed sale
RA Capital Healthcare Fund LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
218,043
29.00
US$6,323,247 		218,043 29.00 US$6,323,247
2025-10-17 2025-10-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
2,492 -14.2%
31.00
US$77,252 		2,492 -14.2% 31.00 US$77,252
2025-10-17 2025-10-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
12,691 -0.8%
31.00
US$393,421 		12,691 -0.8% 31.00 US$393,421
2025-10-17 2025-10-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
6,040 -25.6%
30.28
US$182,891 		6,040 -25.6% 30.28 US$182,891
2025-10-17 2025-10-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
30,758 -2.0%
30.28
US$931,352 		30,758 -2.0% 30.28 US$931,352
2025-10-17 2025-10-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
34,284 -59.2%
29.12
US$998,350 		34,284 -59.2% 29.12 US$998,350
2025-10-17 2025-10-17 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
174,594 -10.1%
29.12
US$5,084,177 		174,594 -10.1% 29.12 US$5,084,177
2025-10-17 2025-10-16 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
2,021 -0.2%
30.45
US$61,549 		2,021 -0.2% 30.45 US$61,549
2025-10-17 2025-10-16 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
4 -0.0%
31.35
US$125 		4 -0.0% 31.35 US$125
2025-10-17 2025-10-16 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
20 -0.0%
31.35
US$627 		20 -0.0% 31.35 US$627
2025-10-17 2025-10-16 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
3,108 -5.1%
30.36
US$94,359 		3,108 -5.1% 30.36 US$94,359
2025-10-17 2025-10-16 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
15,826 -0.9%
30.36
US$480,477 		15,826 -0.9% 30.36 US$480,477
2025-10-17 2025-10-16 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
21,804 -26.3%
29.32
US$639,293 		21,804 -26.3% 29.32 US$639,293
2025-10-17 2025-10-16 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
111,041 -6.0%
29.32
US$3,255,722 		111,041 -6.0% 29.32 US$3,255,722
2025-10-16 2025-10-16 PrS Proposed sale
RA Capital Nexus Fund, L.P.

Director; 10% Stockholder

Non-Executive Director Large shareholder
24,916
29.06
US$724,059 		24,916 29.06 US$724,059
2025-10-16 2025-10-16 PrS Proposed sale
RA Capital Healthcare Fund LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
126,887
29.06
US$3,687,336 		126,887 29.06 US$3,687,336
2025-10-17 2025-10-15 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
7,894 -0.7%
32.77
US$258,712 		7,894 -0.7% 32.77 US$258,712
2025-10-17 2025-10-15 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
48,910 -3.9%
32.05
US$1,567,365 		48,910 -3.9% 32.05 US$1,567,365
2025-10-17 2025-10-15 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
14,851 -1.2%
31.05
US$461,118 		14,851 -1.2% 31.05 US$461,118
2025-10-17 2025-10-15 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
46 -0.1%
31.17
US$1,434 		46 -0.1% 31.17 US$1,434
2025-10-17 2025-10-15 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
234 -0.0%
31.17
US$7,294 		234 -0.0% 31.17 US$7,294
2025-10-17 2025-10-15 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
8,384 -9.2%
30.55
US$256,131 		8,384 -9.2% 30.55 US$256,131
2025-10-17 2025-10-15 S Sale
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
42,699 -2.3%
30.55
US$1,304,454 		42,699 -2.3% 30.55 US$1,304,454
2025-10-15 2025-10-15 PrS Proposed sale
RA Capital Nexus Fund, L.P.

Director; 10% Stockholder

Non-Executive Director Large shareholder
8,430
30.22
US$254,755 		8,430 30.22 US$254,755
2025-10-15 2025-10-15 PrS Proposed sale
RA Capital Healthcare Fund LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
42,933
30.22
US$1,297,435 		42,933 30.22 US$1,297,435
2025-10-15 2025-10-14 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
33,668 -2.6%
30.32
US$1,020,787 		33,668 -2.6% 30.32 US$1,020,787
2025-10-15 2025-10-13 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
2,334 -0.2%
33.09
US$77,226 		2,334 -0.2% 33.09 US$77,226
2025-10-15 2025-10-13 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
19,672 -1.5%
32.36
US$636,560 		19,672 -1.5% 32.36 US$636,560
2025-10-15 2025-10-10 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
40,983 -3.0%
30.97
US$1,269,133 		40,983 -3.0% 30.97 US$1,269,133
2025-10-10 2025-10-09 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
15,042 -1.1%
32.41
US$487,439 		15,042 -1.1% 32.41 US$487,439
2025-10-10 2025-10-09 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
33,842 -2.4%
31.92
US$1,080,172 		33,842 -2.4% 31.92 US$1,080,172
2025-10-10 2025-10-08 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
14,336 -1.0%
34.34
US$492,285 		14,336 -1.0% 34.34 US$492,285
2025-10-10 2025-10-08 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
60,926 -4.1%
33.75
US$2,056,472 		60,926 -4.1% 33.75 US$2,056,472
2025-10-08 2025-10-07 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
27,624 -1.8%
33.84
US$934,711 		27,624 -1.8% 33.84 US$934,711
2025-10-08 2025-10-06 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
18,156 -1.2%
37.77
US$685,830 		18,156 -1.2% 37.77 US$685,830
2025-10-08 2025-10-06 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
34,847 -2.2%
37.12
US$1,293,566 		34,847 -2.2% 37.12 US$1,293,566
2025-10-08 2025-10-06 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
17,760 -1.1%
36.00
US$639,392 		17,760 -1.1% 36.00 US$639,392
2025-10-03 2025-10-03 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
4,701 -0.3%
38.14
US$179,317 		4,701 -0.3% 38.14 US$179,317
2025-10-03 2025-10-03 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
3,200 -0.2%
37.37
US$119,594 		3,200 -0.2% 37.37 US$119,594
2025-10-03 2025-10-02 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
5,300 -0.3%
42.32
US$224,291 		5,300 -0.3% 42.32 US$224,291
2025-10-03 2025-10-02 S Sale
4.1
Reprogrammed Interchange LLC
Large shareholder
13,001 -0.8%
40.13
US$521,707 		13,001 -0.8% 40.13 US$521,707
Explore more

More insider trading research around Vor Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America